Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

The education ministry is planning a nationwide smart classroom initiative and AI-assisted tools for teachers. Additionally, a significant revamp of the National Talent Search Examination (NTSE) is ...

Five Point Holdings LLC (NYSE: FPH) stock jumped 36% to $5.53 with a market cap of $824.2 million. The Irvine-based real estate company announced a record-high quarterly income of $121 million during ...

National Engineering Research Center for Advanced Polymer Processing Technology, Zhengzhou University, Zhengzhou 450002, China ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...

In 2019, Stan­ford Uni­ver­si­ty pro­fes­sor Irv Weiss­man and a col­league pub­lished a pa­per that rep­re­sent­ed a new way to tar­get some ag­gres­sive can­cers.

Prolium was set up by RTW in 2024. Last year also saw the New York-based investment fund involved in the launch of obesity biotech Kailera Therapeutics, which RTW said at the time was the fourth ...

But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage ...

Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China ...

The Chi­na-to-US ex­per­i­men­tal med­i­cine pipeline is bal­loon­ing: yet an­oth­er US-based biotech formed around a can­di­date from Chi­na’s Keymed Bio­sciences on Mon­day.

Prolium will make a $17.5m upfront payment, with potential milestone payments totalling $502.5m. Credit: uniquepixel via Getty Images. Investment company RTW Investments has launched a new biotech ...